D2C Healthcare Marketing: FSSAI + AYUSH + CDSCO

Direct-to-consumer healthcare in India spans a remarkably diverse product landscape: ayurveda supplements, nutraceuticals, diagnostics kits, medical devices for home use, OTC pharmaceutical products, and digital health services. Each category sits under a different regulatory authority — and each has different rules for what can be claimed in marketing.

The three primary regulators in D2C healthcare:

• FSSAI (Food Safety and Standards Authority of India): governs food products, nutraceuticals, functional foods, and food supplements
• AYUSH Ministry: governs Ayurveda, Yoga, Unani, Siddha, and Homeopathy products
• CDSCO (Central Drugs Standard Control Organisation): governs pharmaceuticals, medical devices, and diagnostics

Getting the regulatory category right is the first marketing decision. A product categorised incorrectly — claiming to be a "food supplement" when it is actually making drug claims — invites enforcement from multiple authorities simultaneously.

Categorising Your D2C Product: The Foundation Step

ICG's first step with every D2C healthcare client is regulatory categorisation:

Is it a food product? If the product is a nutraceutical, dietary supplement, functional food, or fortified food — it falls under FSSAI. Key FSSAI categories: Nutraceuticals, Dietetic Products, Fortified Foods, Organic Foods.

Is it an AYUSH product? If the product is formulated using classical Ayurvedic, Unani, Siddha, or Homeopathic principles — it falls under the Drugs and Cosmetics Act (Ayurvedic provisions) regulated via AYUSH. Manufacturing license requirement: Ayurvedic Drug Manufacturing License (state-level).

Is it a pharmaceutical? If the product contains scheduled substances, makes specific therapeutic claims, or is intended to treat, prevent, or cure a disease — it is likely a pharmaceutical regulated by CDSCO. OTC products on Schedule K are regulated differently from prescription drugs.

Is it a medical device? Home diagnostic kits, blood glucose monitors, pulse oximeters, thermometers, and many digital health devices fall under the Medical Devices Rules, 2017 (CDSCO). Marketing of medical devices must comply with MDR 2017 claim standards.

Can it be multiple categories? Yes — and this is the most common source of regulatory confusion. Ashwagandha root extract capsules can be a nutraceutical (FSSAI) if marketed for general wellness, or an Ayurvedic proprietary medicine (AYUSH) if marketed per classical formulation. The marketing claim determines the regulatory category — not the ingredient.

FSSAI Claim Standards: What D2C Brands Must Know

FSSAI permits two types of claims for food products and nutraceuticals:

Nutrient content claims: Statements about the amount of a nutrient in the product. "Contains 500mg Vitamin C per serving." These are factual claims and FSSAI-permissible if accurate.

Health claims: The most regulated category. FSSAI's Health Claims Regulations (2018) permit only claims that have been pre-approved or are based on FSSAI-accepted scientific evidence.

Examples of pre-approved health claims: "Calcium contributes to normal bone health." "Iron contributes to normal oxygen transport in the body."

Examples of claims that require substantiation: "This product reduces cholesterol." "This supplement improves cognitive function." (These require FSSAI-standard clinical evidence to support.)

Examples of claims that are prohibited entirely: "Cures diabetes." "Prevents cancer." (Schedule J + FSSAI violation.)

Amazon Performance for D2C Healthcare

Amazon India is the highest-intent digital shelf for D2C healthcare products. A customer searching "ashwagandha supplement India" on Amazon is within minutes of purchasing. ICG's Amazon performance framework for D2C healthcare:

Listing optimisation:

• Product title: primary ingredient/benefit keyword + brand name + form (capsules/powder/liquid) + quantity
• Bullet points: 5 bullets covering key claims (FSSAI/AYUSH-compliant), certifications, dosage, sourcing
• Product description: educational, detailed, evidence-referenced
• A+ Content: brand story, ingredient sourcing imagery, scientific backing section
• Brand Store: consolidated brand presence for multi-product ranges

Sponsored Products: High-intent keyword targeting: ingredient keywords ("ashwagandha capsules", "whey protein India"), category keywords ("immunity supplement", "sleep supplement India"), competitor brand keywords.

Sponsored Brands: Brand awareness at category-level search. Video ads performing strongly for health supplements on Amazon India.

Compliance on Amazon: Amazon India has a moderated health claims policy. Products making disease-treatment claims (Schedule J conditions) are at risk of listing suppression. ICG builds Amazon listings with FSSAI-compliant wellness framing — avoiding the claims that trigger listing issues while maintaining conversion impact.

Quick Commerce: The New Healthcare Channel

Blinkit, Zepto, Swiggy Instamart, and BigBasket NOW have emerged as meaningful channels for repeat-purchase healthcare products: vitamins, supplements, OTC medicines, hygiene products. In urban metros, Quick Commerce accounts for 20-35% of nutraceutical and OTC supplement repeat purchases for brands with distribution in these channels.

ICG's Quick Commerce strategy for D2C healthcare clients:

• Prioritise high-frequency consumables (daily vitamins, protein supplements, digestive health products) for Quick Commerce listing
• Optimise within-app search ranking (equivalent to Amazon SEO, within each Quick Commerce app)
• Bundle Quick Commerce with subscription economics: "Subscribe on Blinkit for 10% off monthly delivery"
• Treat Quick Commerce as retention channel, not acquisition — the first purchase is typically through Amazon or brand website, repeat through Quick Commerce

Subscription Economics: CAC-to-LTV Framework

The defining financial metric for D2C healthcare brands is not CPQL — it is CAC-to-LTV. ICG's framework:

Customer Acquisition Cost (CAC): Total media spend + agency fees ÷ new customers acquired in the period

Lifetime Value (LTV): Average order value × purchase frequency × customer lifespan (months)

Payback period: CAC ÷ (gross margin per month from a retained customer)

For supplement brands with strong retention (a well-formulated supplement that genuinely works retains 65-80% of customers through month 3), a payback period of 2-4 months is achievable. Beyond the payback point, every retained customer is pure margin.

ICG targets a maximum 90-day payback period for D2C healthcare clients. Ad spend is calibrated to this constraint — meaning we will not scale spend beyond the volume that maintains a ≤90 day payback at current LTV.

ICG's D2C Healthcare Practice

ICG's D2C practice covers ayurveda, nutraceuticals, diagnostics, OTC pharmaceuticals, and health-tech products. The regulatory compliance framework (FSSAI + AYUSH + CDSCO) is built into every content and campaign brief.

Read next on ICG

• D2C healthcare marketing agency India
• Ayurveda marketing — AYUSH compliant
• Performance marketing for healthcare